Horner M, Popp S, Branchu J, Stevanin G, Darios F, Klebe S
Front Neurosci. 2024; 18:1299554.
PMID: 38435059
PMC: 10904495.
DOI: 10.3389/fnins.2024.1299554.
Hernandez C, Kargarnovin S, Hejazi S, Karwowski W
Front Comput Neurosci. 2023; 17:1207067.
PMID: 37457899
PMC: 10344458.
DOI: 10.3389/fncom.2023.1207067.
Walker L, Berard J, Islam T, Pilutti L, Morrow S, Finlayson M
Front Rehabil Sci. 2022; 3:999266.
PMID: 36518350
PMC: 9742940.
DOI: 10.3389/fresc.2022.999266.
Kouvatsou Z, Masoura E, Kimiskidis V
Front Psychol. 2022; 13:866885.
PMID: 35572228
PMC: 9097870.
DOI: 10.3389/fpsyg.2022.866885.
Saeedi R, Rezaeimanesh N, Sahraian M, Naser Moghadasi A
Iran J Psychiatry. 2021; 16(3):336-342.
PMID: 34616468
PMC: 8452838.
DOI: 10.18502/ijps.v16i3.6260.
Presenting Symptoms and Disease Severity in Multiple Sclerosis Patients.
Ledesma J, Puttagunta P, Torabi S, Berube K, Tamrazian E, Garcia D
Neurol Int. 2021; 13(1):18-24.
PMID: 33430058
PMC: 7838821.
DOI: 10.3390/neurolint13010002.
Experimental autoimmune encephalopathy (EAE)-induced hippocampal neuroinflammation and memory deficits are prevented with the non-opioid TLR2/TLR4 antagonist (+)-naltrexone.
Kwilasz A, Todd L, Duran-Malle J, Schrama A, Mitten E, Larson T
Behav Brain Res. 2020; 396:112896.
PMID: 32905811
PMC: 7572683.
DOI: 10.1016/j.bbr.2020.112896.
Fatigue and Suicidal Ideation in People With Multiple Sclerosis: The Role of Social Support.
Mikula P, Timkova V, Linkova M, Vitkova M, Szilasiova J, Nagyova I
Front Psychol. 2020; 11:504.
PMID: 32256439
PMC: 7093596.
DOI: 10.3389/fpsyg.2020.00504.
A longitudinal study of cognitive function in multiple sclerosis: is decline inevitable?.
Katsari M, Kasselimis D, Giogkaraki E, Breza M, Evangelopoulos M, Anagnostouli M
J Neurol. 2020; 267(5):1464-1475.
PMID: 32008073
DOI: 10.1007/s00415-020-09720-8.
Cognitive Fatigability Interventions in Neurological Conditions: A Systematic Review.
Walker L, Lindsay-Brown A, Berard J
Neurol Ther. 2019; 8(2):251-271.
PMID: 31586303
PMC: 6858900.
DOI: 10.1007/s40120-019-00158-3.
Imaging cognitive fatigability in multiple sclerosis: objective quantification of cerebral blood flow during a task of sustained attention using ASL perfusion fMRI.
Berard J, Fang Z, Walker L, Lindsay-Brown A, Osman L, Cameron I
Brain Imaging Behav. 2019; 14(6):2417-2428.
PMID: 31468375
DOI: 10.1007/s11682-019-00192-7.
Hair cortisol concentration, cognitive, behavioral, and motor impairment in multiple sclerosis.
Pereira G, Becker J, Soares N, de Azeredo L, Grassi-Oliveira R, Rysdyk A
J Neural Transm (Vienna). 2019; 126(9):1145-1154.
PMID: 31250284
DOI: 10.1007/s00702-019-02040-w.
Overview: A Framework for the Discussion of Sleep in Multiple Sclerosis.
Braley T
Curr Sleep Med Rep. 2018; 3(4):263-271.
PMID: 30034994
PMC: 6051415.
A Comparison of Implicit and Explicit Motor Sequence Learning in Patients with Relapsing-Remitting Multiple Sclerosis.
Sarabandi M
Sports (Basel). 2018; 5(2).
PMID: 29910394
PMC: 5968985.
DOI: 10.3390/sports5020034.
A Longitudinal Evaluation of Cognitive Fatigue on a Task of Sustained Attention in Early Relapsing-Remitting Multiple Sclerosis.
Berard J, Smith A, Walker L
Int J MS Care. 2018; 20(2):55-61.
PMID: 29670491
PMC: 5898916.
DOI: 10.7224/1537-2073.2016-106.
Progressive multiple sclerosis and mood disorders.
Lorefice L, Fenu G, Trincas G, Moro M, Frau J, Coghe G
Neurol Sci. 2015; 36(9):1625-31.
PMID: 25899424
DOI: 10.1007/s10072-015-2220-3.
Cognitive rehabilitation in multiple sclerosis: the role of plasticity.
Chiaravalloti N, Genova H, DeLuca J
Front Neurol. 2015; 6:67.
PMID: 25883585
PMC: 4383043.
DOI: 10.3389/fneur.2015.00067.
Unmet care needs of people with a neurological chronic disease: a cross-sectional study in Italy on Multiple Sclerosis.
Ponzio M, Tacchino A, Zaratin P, Vaccaro C, Battaglia M
Eur J Public Health. 2015; 25(5):775-80.
PMID: 25829501
PMC: 4582845.
DOI: 10.1093/eurpub/ckv065.
Pain is associated with prospective memory dysfunction in multiple sclerosis.
Miller A, Basso M, Candilis P, Combs D, Woods S
J Clin Exp Neuropsychol. 2014; 36(8):887-96.
PMID: 25338929
PMC: 4229443.
DOI: 10.1080/13803395.2014.953040.
Determining the Presence of Reliable Change over Time in Multiple Sclerosis: Evidence from the PASAT, Adjusting-PSAT, and Stroop Test.
Barker-Collo S, Purdy S
Int J MS Care. 2014; 15(4):170-8.
PMID: 24453780
PMC: 3883014.
DOI: 10.7224/1537-2073.2013-007.